Thursday 22 November 2012 – UCB Pharma, Braine l'Alleud, Belgium
Preliminary Program
You can download this program from the pdf in attachment at the bottom of this page.
|
8:30-9:00 |
Coffee |
|
|
9:00-9:10 |
Welcome |
|
|
Morning session: Introductory lectures |
||
|
9:10-10:10 |
Vaccine Regulatory Toxicology – update on recent EMA and WHO guideline revisions |
C. Herberts, Medicines Evaluation Board, Nl |
|
10:10-10:30 |
Coffee break
|
|
| 10:30-11:15 |
Different approaches in DART testing driven by biopharmaceutical subclasses |
M. Beekhuijzen, WIL Research, Nl |
|
11:15-12:00 |
Juvenile toxicology for biopharmaceuticals
|
P. Baldrick, Covance, UK |
|
12:00-13:00 |
Lunch and networking |
|
|
Afternoon session: Case studies (chair : J. Sims, Integrated Biologix, UK) |
||
|
13:00-13:15 |
Introduction to breakout sessions |
A. Cauvin, UCB Pharma, B |
| 13:15-14:30 | Breakout sessions |
|
|
14:30-14:50 |
Coffee break |
|
|
14:50-16:50 |
Case study reporting and discussion |
participants |
|
16:50-17:00 |
Concluding remarks |
|
|
Organising Committee : Judith Baumeister (Ablynx), Annick Cauvin (UCB Pharma),
Miranda Cornet (UCB Pharma), Michaela Damsten (GSK Vaccines), Ilham Smyej (Johnson & Johnson), Lawrence Segal (GSK Vaccines) with the technical assistance of Marleen Hallam (BelTox) and Catherine Vos (UCB Pharma) |
||